Apr 1 |
Earnings Scheduled For April 1, 2024
|
Mar 20 |
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
|
Mar 14 |
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
|
Mar 13 |
Zomedica says talks ongoing with NYSE American to regain listing compliance
|
Mar 13 |
Zomedica Provides NYSE American Listing Update
|
Mar 12 |
Sidoti Events, LLC's Virtual March Small-Cap Conference
|
Mar 12 |
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
|
Mar 7 |
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
|
Mar 5 |
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
|
Feb 8 |
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
|